C. Keller

发表

The effect of the apolipoprotein E polymorphism on lipid levels in patients with familial defective apolipoprotein B-100

H. Schuster, C. Manke, C. Keller, 1993, The clinical investigator.

Xeroradiographic determination of Achilles tendon thickness in familial hypercholesterolemia confirmed by tissue cultures.

N. Zöllner, C. Keller, G. Wolfram, 1983, Atherosclerosis.

Effect of triiodothyronine on triglyceride synthesis in human fibroblasts in different types of hypertriglyceridemia.

N. Zöllner, C. Keller, G. Wolfram, 1990, Metabolism: clinical and experimental.

Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate.

V. Armstrong, F. Beil, H. Greten, 1994, The American journal of medicine.

Highly Resistant Metabolically Deficient Dwarf Mutant of Escherichia coli Is the Cause of a Chronic Urinary Tract Infection

J. Heesemann, S. Schubert, K. Trülzsch, 2003, Journal of Clinical Microbiology.

Apheresis in Coronary Heart Disease With Elevated Lp (a): A Review of Lp (a) As a Risk Factor and Its Management

C. Keller, 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Relation of lipoprotein(a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia.

H. Schuster, N. Zöllner, C. Keller, 1993, Atherosclerosis.

Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia

F. Tató, C. Keller, G. Wolfram, 1993, The clinical investigator.

Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue culture.

T. Demant, N. Zöllner, C. Keller, 1985, Atherosclerosis.

Ten LDL receptor mutants explain one third of familial hypercholesterolemia in a German sample.

H. Schuster, N. Zöllner, C. Keller, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Identification of a silent point mutation in the LDL-receptor gene by direct DNA sequencing

H. Schuster, N. Zöllner, C. Keller, 1991, Klinische Wochenschrift.

Identification of the serine-156 to leucine mutation in the low-density lipoprotein receptor in a German family with familial hypercholesterolemia

H. Schuster, C. Keller, G. Wolfram, 1993, The clinical investigator.

Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B‐100

H. Schuster, N. Zöllner, C. Keller, 1994, European journal of clinical investigation.

Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich.

S. Humphries, S. Humphries, H. Schuster, 1990, Arteriosclerosis.

Independent mutation of arginine(3500)-->glutamine associated with familial defective apolipoprotein B-100.

H. Schuster, N. Zöllner, C. Keller, 1993, Journal of lipid research.

Familial defective apolipoprotein B100: clinical characteristics of 54 cases.

H. Schuster, N. Zöllner, C. Keller, 1992, Atherosclerosis.

Allele-specific and asymmetric polymerase chain reaction amplification in combination: a one step polymerase chain reaction protocol for rapid diagnosis of familial defective apolipoprotein B-100.

H. Schuster, N. Zöllner, C. Keller, 1992, Analytical biochemistry.

Identification of the valine 408 to methionine mutation in the LDL receptor in a Greek patient with homozygous familial hypercholesterolemia

H. Schuster, C. Manke, C. Keller, 1995, Clinical genetics.

Identification of a heterozygous compound individual with familial hypercholesterolemia and familial defective apolipoprotein B-100

H. Schuster, N. Zöllner, C. Keller, 1991, Klinische Wochenschrift.

Identification of the 408 valine to methionine mutation in the low density lipoprotein receptor in a German family with familial hypercholesterolemia

H. Schuster, N. Zöllner, C. Keller, 1993, Human Genetics.

Hepatic cholesterol synthesis in patients with familial hypercholesterolemia (FHC) proven by fibroblast culture.

N. Zöllner, C. Keller, A. Wieczorek, 1980, Atherosclerosis.

Association of DNA‐haplotypes in the human LDL‐receptor gene with normal serum cholesterol levels

S. Humphries, H. Schuster, N. Zöllner, 1990, Clinical genetics.

Serum cholesterol levels in patients with familial hypercholesterolemia confirmed by tissue culture.

N. Zöllner, C. Keller, G. Wolfram, 1981, Atherosclerosis.

First international workshop on familial defective apo B-100

S. Humphries, H. Schuster, C. Keller, 1992, The clinical investigator.

LDL-apheresis: results of longterm treatment and vascular outcome.

C. Keller, 1991, Atherosclerosis.

The treatment of hypercholesterolemia with beta-pyridylcarbinol. Part 5. Report on 16 cases with severe hypercholesterolemia treated for 12 years.

N. Zöllner, C. Keller, G. Wolfram, 1977, Atherosclerosis.

Unusual but reversible hepatic lesions following long-term treatment with pyridylcarbinol for familial hypercholesterolemia

N. Zöllner, C. Keller, G. Wolfram, 1988, Klinische Wochenschrift.

Familial defective apolipoprotein B-100: haplotype analysis of the arginine(3500)----glutamine mutation.

H. Schuster, N. Zöllner, C. Keller, 1991, Atherosclerosis.

Identification of a 76-year-old patient with compound heterozygous Familial Hypercholesterolemia by haplotype analysis of the LDL receptor gene

H. Schuster, N. Zöllner, C. Keller, 1991, Klinische Wochenschrift.

Use of DNA haplotype analysis in diagnosis of familial hypercholesterolaemia in 31 German families.

H. Schuster, N. Zöllner, C. Keller, 1991, Journal of medical genetics.

Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.

S. Schewe, H. Schuster, N. Zöllner, 1990, Atherosclerosis.

Reduction of lp(a) by different methods of plasma exchange

N. Zöllner, C. Keller, G. Wolfram, 1988, Klinische Wochenschrift.

Screening for functional sequence variations and mutations in ABCA1.

T. Langmann, G. Schmitz, C. Buechler, 2004, Atherosclerosis.

[First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].

N. Zöllner, C. Keller, G. Wolfram, 1973, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin.

Familial defective apolipoprotein B-100: a common cause of primary hypercholesterolemia

H. Schuster, N. Zöllner, C. Keller, 2004, The clinical investigator.

I nde pendent m u tat ion of arg i n i ne(3500) -+ g I u tam i ne associated with familial defective apoli poprotein B-I 00

H. Schuster, N. Zöllner, C. Keller, 1993 .

Metabolic abnormalities in a patient with muscular carnitine deficiency

C. Barth, C. Keller, G. Wolfram, 1981, Journal of Inherited Metabolic Disease.

Effects of Chenodeoxycholic Acid (CD) Treatment on Endogenous Plasma Triglyceride (TG) Transport in Hyperlipoproteinemia (HLP)

T. M. Hayes, M. Freeman, S. Fujii, 1978 .

Pleural effusions in acute mononucleosis.

B. Gathof, N. Zöllner, C. Keller, 1991, Bildgebung = Imaging.

Four DNA polymorphisms in the LDL-receptor gene and their use in diagnosis of familial hypercholesterolemia

S. Humphries, H. Schuster, N. Zöllner, 1989, Human Genetics.

Diagnosis of familial hypercholesterolemia using DNA haplotype analysis in three large families with two hyperlipidemic parents.

H. Schuster, N. Zöllner, C. Keller, 1992, Annals of Nutrition and Metabolism.

Atherosclerosis of the carotid arteries documented by Duplex scan as a predictor of coronary artery disease in familial hyperlipidemias

H. Schuster, N. Zöllner, C. Keller, 1987, Klinische Wochenschrift.